Open Access

ARTICLE

Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib

Yueming He^*1, Wang Sheng^†1, Weiguo Hu^‡1, Jing Lin^§, Junjun Liu^§, Bing Yu^§, Xinru Mao^§, Lu Zhang^§, Jin Huang^¶, Guangsuo Wang^#

* Department of Respiration, Quanzhou First Hospital, Fujian Medical University, Quanzhou, P.R. China
† Department of Medical Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, P.R. China
‡ Center of Oncology, Renmin Hospital of Wuhan University, Wuhan, P.R. China
§ Burning Rock Biotech, Guangzhou, P.R. China
¶ Department of Oncology, Xiangya Hospital, Central South University, Changsha, P.R. China
# Department of Thoracic Surgery, Shenzhen People’s Hospital, Second Affiliated Hospital, Medical College of Ji’nan University, Shenzhen, P.R. China